Herbalife (HLF) Expected to Announce Quarterly Earnings on Wednesday

Key Points

• Herbalife is set to announce its Q2 2025 quarterly earnings on August 6th, with analysts anticipating earnings of $0.53 per share and revenue of $1.27 billion.
• In the previous quarter, Herbalife reported earnings of $0.59 per share, exceeding estimates, although its revenue declined by 3.4% year-over-year.
• Several analysts have issued updated ratings on Herbalife, with a consensus rating of "Moderate Buy" and a price target of $11.50.

Herbalife (NYSE:HLF - Get Free Report) is anticipated to issue its Q2 2025 quarterly earnings data after the market closes on Wednesday, August 6th. Analysts expect the company to announce earnings of $0.53 per share and revenue of $1.27 billion for the quarter.

Herbalife (NYSE:HLF - Get Free Report) last released its quarterly earnings results on Wednesday, April 30th. The company reported $0.59 earnings per share for the quarter, beating analysts' consensus estimates of $0.40 by $0.19. Herbalife had a negative return on equity of 23.75% and a net margin of 5.66%. The business had revenue of $1.22 billion during the quarter, compared to analyst estimates of $1.23 billion. During the same quarter last year, the company posted $0.49 EPS. Herbalife's revenue for the quarter was down 3.4% on a year-over-year basis.

Herbalife Stock Performance

Shares of HLF stock traded down $0.28 on Wednesday, reaching $9.16. 1,595,385 shares of the company's stock traded hands, compared to its average volume of 1,816,558. The business's 50 day moving average price is $8.64 and its two-hundred day moving average price is $7.63. The company has a market capitalization of $932.95 million, a P/E ratio of 3.34, a price-to-earnings-growth ratio of 0.28 and a beta of 0.89. Herbalife has a 12-month low of $5.04 and a 12-month high of $12.79.

Insider Buying and Selling at Herbalife

In other Herbalife news, Director Juan Miguel Mendoza purchased 5,000 shares of the firm's stock in a transaction dated Thursday, May 22nd. The stock was purchased at an average price of $6.75 per share, for a total transaction of $33,750.00. Following the completion of the purchase, the director directly owned 166,857 shares of the company's stock, valued at $1,126,284.75. This trade represents a 3.09% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Over the last 90 days, insiders have bought 13,143 shares of company stock worth $90,973. Insiders own 1.73% of the company's stock.

Hedge Funds Weigh In On Herbalife

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. AQR Capital Management LLC grew its holdings in shares of Herbalife by 236.8% during the 1st quarter. AQR Capital Management LLC now owns 133,245 shares of the company's stock worth $1,150,000 after purchasing an additional 93,686 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Herbalife by 3.3% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 210,904 shares of the company's stock worth $1,820,000 after purchasing an additional 6,747 shares in the last quarter. Empowered Funds LLC boosted its holdings in shares of Herbalife by 12.9% during the 1st quarter. Empowered Funds LLC now owns 30,301 shares of the company's stock valued at $261,000 after acquiring an additional 3,474 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Herbalife by 4.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 59,964 shares of the company's stock valued at $517,000 after acquiring an additional 2,523 shares during the period.

Wall Street Analysts Forecast Growth

HLF has been the subject of a number of recent analyst reports. Mizuho upped their price target on shares of Herbalife from $8.00 to $9.00 and gave the company a "neutral" rating in a report on Monday. Citigroup cut their target price on Herbalife from $13.00 to $11.00 and set a "buy" rating on the stock in a research note on Thursday, May 1st. Finally, Wall Street Zen raised shares of Herbalife from a "hold" rating to a "buy" rating in a research report on Friday, May 30th. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, Herbalife presently has a consensus rating of "Moderate Buy" and a consensus price target of $11.50.

About Herbalife

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.